HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diana Spiegelberg Selected Research

Colonic Neoplasms (Colon Cancer)

1/2014Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Diana Spiegelberg Research Topics

Disease

16Neoplasms (Cancer)
10/2023 - 10/2011
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2016 - 02/2014
2Neoplasm Metastasis (Metastasis)
12/2022 - 10/2022
2Head and Neck Neoplasms (Head and Neck Cancer)
10/2022 - 01/2020
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2012
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020 - 12/2019
2Squamous Cell Carcinoma of Head and Neck
01/2017 - 10/2011
1Thyroid Neoplasms (Thyroid Cancer)
10/2023
1Prostatic Neoplasms (Prostate Cancer)
12/2022
1Residual Neoplasm
10/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2020
1Adenocarcinoma
11/2015
1Carcinoma (Carcinomatosis)
09/2014
1Colonic Neoplasms (Colon Cancer)
01/2014

Drug/Important Bio-Agent (IBA)

7(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA
10/2023 - 11/2015
5Proteins (Proteins, Gene)FDA Link
12/2022 - 02/2014
3ErbB Receptors (EGF Receptor)IBA
09/2014 - 10/2011
2Sorafenib (BAY 43-9006)FDA Link
10/2023 - 01/2020
2Tyrosine Kinase InhibitorsIBA
10/2023 - 01/2020
2AntibodiesIBA
12/2022 - 01/2017
2Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020 - 12/2019
2Therapeutic UsesIBA
01/2020 - 01/2019
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020 - 11/2015
2Peptides (Polypeptides)IBA
01/2019 - 01/2018
2Immunoglobulin FragmentsIBA
02/2016 - 01/2016
2Radioisotopes (Radionuclides)IBA
11/2015 - 10/2011
1Drug CombinationsIBA
10/2023
1EpitopesIBA
12/2022
1DNA (Deoxyribonucleic Acid)IBA
12/2022
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
12/2022
1radium Ra 223 dichlorideIBA
12/2022
1RadiopharmaceuticalsIBA
12/2022
1Hemoglobins (Hemoglobin)IBA
10/2022
1C-Reactive ProteinIBA
10/2022
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2022
1Tumor Suppressor Protein p53IBA
01/2022
1A-factor (Streptomyces)IBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1antineoplaston A10 (A 10)IBA
01/2020
1lutetium Lu 177 dotatateIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
05/2016
1Surface Antigens (Surface Antigen)IBA
05/2016
1AntigensIBA
05/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2016
1CD44v6 antigenIBA
02/2016
1Glucose (Dextrose)FDA LinkGeneric
02/2016
1Immunoglobulin Fab FragmentsIBA
03/2014
1IsotopesIBA
03/2014
1Fluorescein-5-isothiocyanate (FITC)IBA
02/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2014
1Protein Isoforms (Isoforms)IBA
01/2014
1Growth Factor ReceptorsIBA
10/2011
1Epidermal Growth Factor (EGF)IBA
10/2011

Therapy/Procedure

9Therapeutics
10/2023 - 11/2015
5Radiotherapy
01/2022 - 01/2018
1Radioimmunotherapy
05/2016